Nanobiotix S.A. (NBTX)
USD 3.52
(-0.57%)
USD 3.52
(-0.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.47 Million | -37.1 Million | -29.87 Million | -27.53 Million | -41.16 Million | -25.98 Million |
| Net Income | -39.7 Million | -57.04 Million | -47 Million | -33.59 Million | -50.91 Million | -30.34 Million |
| Depreciation & Amortization | 1.51 Million | 1.5 Million | 1.56 Million | 1.75 Million | 1.76 Million | 619 Thousand |
| Deferred income taxes | 120 Thousand | - | 152 Thousand | 5.64 Million | 2.1 Million | - |
| Stock-based compensation | 3.22 Million | 3.17 Million | 3.2 Million | 2.92 Million | 4.32 Million | 1.86 Million |
| Change in working capital | 9.92 Million | 2.29 Million | 11.54 Million | 73 Thousand | -1.52 Million | 1.07 Million |
| Other non-cash items | 11.97 Million | 12.96 Million | 678 Thousand | -4.34 Million | 3.07 Million | 796 Thousand |
| Investing Cash Flow | -349 Thousand | 138 Thousand | -242 Thousand | -112 Thousand | -1.45 Million | 71 Thousand |
| Investments in PPE | -337 Thousand | -93 Thousand | -233 Thousand | -107 Thousand | -1.44 Million | -506 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -12 Thousand | - | -9000.00 | -4000.00 | -16 Thousand | - |
| Sales/Maturities of investments | - | 231 Thousand | - | - | - | 577 Thousand |
| Other Investing Activities | -21 Thousand | 1000.00 | -14 Thousand | -1000.00 | 1000.00 | 577 Thousand |
| Financing Cash Flow | 46.77 Million | -5.65 Million | -5.18 Million | 111.76 Million | 41.48 Million | 14.85 Million |
| Debt repayment | -3.61 Million | -4.73 Million | -3.74 Million | -250 Thousand | -500 Thousand | -927 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 60.15 Million | - | -306 Thousand | 113.65 Million | 30.84 Million | 59 Thousand |
| Other Financing Activities | -2.79 Million | -916 Thousand | -1.13 Million | -1.63 Million | 11.14 Million | 15.71 Million |
| Accounts receivables | -806 Thousand | -101 Thousand | 62 Thousand | -51 Thousand | -85 Thousand | 144 Thousand |
| Accounts payables | 8.67 Million | 2.9 Million | -281 Thousand | -995 Thousand | 2.05 Million | 633 Thousand |
| Inventory | - | -2.9 Million | 281 Thousand | 995 Thousand | -2.05 Million | - |
| Other working capital | 1.61 Million | 2.4 Million | 11.47 Million | 124 Thousand | -1.43 Million | 934 Thousand |
| Cash at beginning of period | 41.38 Million | 83.92 Million | 119.15 Million | 35.09 Million | 36.2 Million | 47.21 Million |
| Cash at end of period | 75.28 Million | 41.38 Million | 83.92 Million | 119.15 Million | 35.09 Million | 36.2 Million |
| Capital Expenditure | -337 Thousand | -93 Thousand | -233 Thousand | -107 Thousand | -1.44 Million | -506 Thousand |
| Effect of forex changes on cash | -51 Thousand | 83 Thousand | 64 Thousand | -63 Thousand | 29 Thousand | 54 Thousand |
| Net cash flow / Change in cash | 33.89 Million | -42.53 Million | -35.23 Million | 84.05 Million | -1.1 Million | -11 Million |
| Free Cash Flow | -12.81 Million | -37.19 Million | -30.1 Million | -27.64 Million | -42.61 Million | -26.49 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.93 Million | -10.93 Million | -5.8 Million | -39.7 Million | -5.8 Million | -28.09 Million |
| Depreciation & Amortization | 393 Thousand | 393 Thousand | 386 Thousand | 1.51 Million | 386 Thousand | 740 Thousand |
| Deferred income taxes | - | - | - | 120 Thousand | - | -180 Thousand |
| Stock-based compensation | 970 Thousand | 970 Thousand | 975.5 Thousand | 3.22 Million | 975.5 Thousand | 674.5 Thousand |
| Change in working capital | -1.24 Million | -1.24 Million | 637.5 Thousand | 9.92 Million | 637.5 Thousand | 5.67 Million |
| Other non-cash items | 7.9 Million | 7.9 Million | 6.2 Million | 11.97 Million | 6.2 Million | -665 Thousand |
| Investing Cash Flow | -250 Thousand | -250 Thousand | -11 Thousand | -349 Thousand | -11 Thousand | -327 Thousand |
| Investments in PPE | -244.5 Thousand | -244.5 Thousand | -2500.00 | -337 Thousand | -2500.00 | -324 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -9000.00 | -12 Thousand | - | -3000.00 |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -5500.00 | -5500.00 | -8500.00 | -21 Thousand | -8500.00 | -2000.00 |
| Financing Cash Flow | -1.32 Million | -1.32 Million | 24.45 Million | 46.77 Million | 24.45 Million | -1.83 Million |
| Debt repayment | - | - | -1.37 Million | -3.61 Million | - | -1.44 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 57.36 Million | 60.15 Million | - | - |
| Other Financing Activities | -1.32 Million | -1.32 Million | 24.45 Million | -2.79 Million | 24.45 Million | -1.06 Million |
| Accounts receivables | -1.1 Million | -1.1 Million | 91.5 Thousand | -806 Thousand | 91.5 Thousand | -1.07 Million |
| Accounts payables | - | - | 1.35 Million | 8.67 Million | - | 7.32 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -139.5 Thousand | -139.5 Thousand | 546 Thousand | 1.61 Million | 546 Thousand | -570 Thousand |
| Cash at beginning of period | - | - | 21.62 Million | 41.38 Million | - | 38.57 Million |
| Cash at end of period | -4.47 Million | -4.47 Million | 75.28 Million | 75.28 Million | 26.82 Million | 21.62 Million |
| Capital Expenditure | -244.5 Thousand | -244.5 Thousand | -2500.00 | -337 Thousand | -2500.00 | -324 Thousand |
| Effect of forex changes on cash | 21.5 Thousand | 21.5 Thousand | -16.5 Thousand | -51 Thousand | -16.5 Thousand | -9000.00 |
| Net cash flow / Change in cash | -4.47 Million | -4.47 Million | 53.65 Million | 33.89 Million | 26.82 Million | -16.94 Million |
| Free Cash Flow | -3.16 Million | -3.16 Million | 2.39 Million | -12.81 Million | 2.39 Million | -17.9 Million |
GABI
GANGESSECU
KAEF
ASTRAMICRO
MX
TBTC